May 14, 2020 / 10:01 PM / 23 days ago

BRIEF-Sellas Life Sciences Reports Q1 Loss Per Share $0.66

May 14 (Reuters) - Sellas Life Sciences Group Inc:

* SELLAS LIFE SCIENCES REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q1 LOSS PER SHARE $0.66

* AS OF MARCH 31, 2020, CASH AND CASH EQUIVALENTS TOTALED APPROXIMATELY $6.7 MILLION

* HAVE BEEN BE ABLE TO CONTINUE TO PROGRESS OUR CLINICAL DEVELOPMENT PROGRAM FOR GALINPEPIMUT-S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below